Advertisement

Topics

J&J ordered to pay $417m fine in cancer talc case

07:03 EDT 22 Aug 2017 | PharmaTimes

Johnson & Johnson has been ordered by a jury in California to pay $417 million to a woman who claims to have developed ovarian cancer from regular use of its talc-based products.

Original Article: J&J ordered to pay $417m fine in cancer talc case

NEXT ARTICLE

More From BioPortfolio on "J&J ordered to pay $417m fine in cancer talc case"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...